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should assist the physician in identifying those patients who are likely to benefit from
revascularization without undue risk.
1080-66 How Efficacious Is Vascular Brachytherapy for the 
Treatment of Ostial In-stent Restenosis?
Eric Eeckhout, Christian Roguelov, Edoardo De Benedetti, Phillippe Coucke, CHUV, 
Lausanne, Switzerland
Background : Percutaneous intervention for ostial coronary disease remains a therapeu-
tic challenge with a trend towards more restenosis. Vascular brachytherapy (VBT) is the
only proven therapy for in-stent-restenosis (ISR). Methods : We sought to evaluate the
efficacy of VBT for ostial ISR based on data extracted from the largest registry on beta
VBT using the Betacath system (Novoste, Norcross, USA).
Results : Out of 878 pts treated by VBT for ISR, 47 presented with ostial ISR. Baseline
clinical, angiographic and procedural data were comparable for both groups except for
vessel size and mean dose (3.16±0.50mm (all, Group 1) vs 3.33±0.52mm (ostial, Group
2) and 18.8±3.10Gy (Group1) vs 23.31±3.90Gy (Group 2), respectively, p<0.05). In par-
ticular in Group 2, vessel type was the left main (10%), the LAD (24%), the Lcx (24%),
the RCA (30%) and a vein graft (12%). Ostial location was aorto-coronary in 51% of
cases, while 49% was coronary-ostial. Technical success was comparable : 96% for
Group 1 and 95% for Group 2 (p=NS). Additional stent use was also similar : 29% (Group
1) vs 35% (Group ). At hospital discharge, myocardial infarction (MI) rate was higher in
the ostial group (0.7% (Group1)vs 2.1% (Group2), p<0.05) and as a potential conse-
quence mortality was higher at 6 months (1.8% (Group 1) vs 6.4% (Group 2), p <0.05).
The overall incidence of adverse events however was comparable (17.9% (Group 1) vs
12.8% (Group2), p=NS).
In conclusion : VBT seems feasible and efficacious in reducing recurrent ISR. However,
potentially because of technical issues, the MI rate is higher during intervention than in a
general ISR population. Consequently, at 6 months follow-up, mortality is also higher.
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1081-47 The Benefit of Coronary Stenting in Small Vessels Is 
Dependent on Reference Vessel Diameter: Results 
From a Meta-Analysis of 11 Randomized Trials
Raul Moreno, Cristina Fernandez, Rosana Hernandez-Antolin, Maria J. Perez-Vizcayno, 
Fernando Alfonso, Javier Escaned, Manel Sabaté, Camino Bañuelos, Carlos Macaya, 
Hospital Clinico San Carlos, Madrid, Spain
Background: The benefit of coronary stenting (CS) in small vessels is still under debate,
since results from randomized studies have yielded controversial results. The aim of this
study was to evaluate the influence of reference vessel diameter (RVD) on the effect of
CS in restenosis in small vessels.
Methods: A meta-analysis including eleven randomized trials on CS versus balloon
angioplasty (BA) in small (<3mm) vessels was performed. A lineal regression equation
was used to evaluate the association between mean RVD and the benefit of CS (RR for
restenosis).
Results: Overall, 3,541 patients were included (1,672 allocated to BA and 1,869 to CS).
Of them, 2,977 (84%) had angiographic re-evaluation at 6 months. RVD at baseline was
similar in patients allocated to BA and CS (2.35 vs. 2.36 mm, p=NS). The pooled rest-
enosis rate was 25.8% and 34.2% in patients allocated to CS and BA, respectively
(p<0.001; risk ratio 0.75; 95% confidence interval 0.67-0.84) [absolute risk reduction
0.07, 95%CI 0.02-0.13, p=0.005]. A smaller RVD at baseline was associated with higher
risk reduction of restenosis (y = - 3.551 + 1.826 [x]; p=0.012) (see figure).
Conclusion: Elective stenting is superior to provisional stenting in small coronary arter-
ies. This benefit is more evident in vessels with smaller RVD.
1081-48 Latin America Small Vessel Randomized Study in 
Diabetic Patients (LASMAL II): Clinical and 
Angiographic Follow-Up Data
Alfredo E. Rodriguez, Maximo Rodriguez Alemparte, Carlos Fernandez Pereira, Victor 
Bernardi, Cesar F. Vigo, Claudio Llaurado, Alberto Sampaolessi, Rocha Loures Bueno, 
The LASMAL investigators, Otamendi Hospital, Buenos Aires, Argentina, Clinica IMA, 
Adrogue, Argentina
Background: There are several randomized studies comparing stent vs PTCA in
patients (pts) with small vessel reference size, however at our knowledge there were no
previous randomized comparison in diabetic pts between PTCA and stents in a popula-
tion with small reference vessel size.
Methods: From February 2001 to July 2003, 220 diabetic pts presenting severe lesion in
small native coronary artery (<2.9 mm) and clinical indication of myocardial revascular-
ization were included in this study . In 9 Latin America centers , pts were randomized to
an initial strategy to PTCA (109) or elective stent therapy (111). A coated posphorylcho-
line small vessel stent (Abbott-BiodivYsio SV) was used in stent arm , lesions in stent
group were always treated previously with conventional balloon technique. The end point
of the study was to compare angiographic binary restenosis, minimal luminal diameter,
net gain,target vessel revascularization (TVR) , target vessel failure (TVF) and major
adverse cardiovascular events(MACE) at six month of follow up between both revascular-
ization strategies.
Results:Both groups had similar baseline, clinical demographic and angiographic char-
acteristics ( Diabetes type II in 92%).After randomization in PTCA group, 24% of the pts
crossed over to stent during the initial procedure. A bolus and 12 hours infusion of abcix-
imab was given in 41% of pts in both groups.Hospital and 30 days outcome were similar
in PTCA and stent group ( MACE 11% vs 7% respectively p=ns ) Long term clinical follow
up ( 12.8+ 8 months) was obtained in 98% of the pts. Six months follow up angiogram
was available in 73% of them. There were no significant differences in TVR ( PTCA
15.6% vs Stent 14.4% p= ns) or incidence of MACE ( PTCA 22.3% vs Stent 18% p= ns)
between both groups whereas TVF ( PTCA 34% vs Stent 18.8% p<0.05) angiographic
restenosis ( PTCA 45% vs Stent 28.5% p<0.043) and net gain ( PTCA 0.74mm vs Stent
0.94mm p= 0.008) were significantly better with stent therapy.Conclusions: This multi-
center randomized study demostrated that an initial strategy with a small vessel stent
design in diabetic pts had a long term follow up lower angiographic restenosis, TVF and
better net gain than those initially treated with PTCA.
1081-49 T-Stenting of Bifurcation Lesions Is Associated With a 
High Incidence of Stent Thrombosis
Francois Gobeil, Chantal Tremblay, Francois Reeves, Guy Leclerc, Roger-Marie Gagnon, 
Alain Rivard, Stephane Rinfret, Notre-Dame Hospital, CHUM, Montreal, PQ, Canada
Background: Bifurcation treatment remains a technical challenge. Stenting of both main
and side branches is associated with good acute angiographic result, but it’s impact on
the risk of stent thrombosis is unknown.
Methods: Between 12-2001 and 01-2003, a total of 96 patients underwent stenting of a
bifurcation lesion at our institution. Baseline and procedure-related data were prospec-
tively collected.
Results: Acute coronary syndrome was the indication for PCI in 88% of patients. Most
lesions involved the LAD-diagonal bifurcation (54%). In 20 patients (21%), 2 stents (2S)
were implanted (T-stenting), mostly because of a residual lesion in the side branch. In the
remaining patients, only one stent (1S) was used. Baseline demographic data were bal-
anced between both groups. Clopidogrel pre-treatment and use of IIbIIIa inhibitors were
similar. There was no difference in mean stent diameter (3.1+ 0.3 mm vs 3.1+ 0.4 mm,
2S vs 1S) and length (20+ 6 mm vs 18+ 6 mm) implanted in the main branch. Stents
were all deployed at 13 + 2 atm. Mean stent diameter and length in the side branch
(group 2S) was 2.6+ 0.4 mm and 12.3+ 0.4 mm respectively. Final kissing balloon infla-
tion was performed in the majority (85% vs 77%, 2S vs 1S, p= 0.45). Side branch resid-
ual stenosis (RS) was significantly lower in the 2S group (4+ 8% vs 19+ 19%, p< 0.001).
However, angiographic success (RS < 30% with stent, RS < 50% without stent, and TIMI
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3 flot) was achieved in 95% of the 2S group and 92% of the 1S group (p=0.66). Stent
thrombosis occurred in 5 patients (25%) of the 2S group at a median of 4.3 days, com-
pared to none (0%) of the 1S group (p< 0.001).
Conclusions: T-stenting of bifurcation lesions does not improve angiographic success
and is associated with a substantial risk of stent thrombosis.
1081-50 Predictors of Target Vessel Revascularization After 
Stenting Coronary Bifurcation Lesions: Insights From a 
Large Prospective Single-Center Database
Gunasekaran Sengottuvel, Thierry Lefèvre, André Kokis, Yves Louvard, Samer Mansour, 
Pierre Dumas, Mehran Monchi, Christophe Loubeyre, Oscar Tavolaro, Marie-Claude 
Morice, Institut Cardiovasculaire Paris Sud, Massy, France
Background: The use of stents is now the gold standard in the majority of coronary
lesions. However, use of bare stents in bifurcation lesions remains controversial.
Methods : We assessed the 7 months outcome and predictors of TVR from a large sin-
gle centre prospective database of patients with bifurcation lesions treated by stent. Fol-
low-up coronary angiogram was performed only in case of clinical or stress test ischemia.
Results: Between 1996-2002, 1149 patients underwent PCI and stent for bifurcation
lesion, age 65+9 years, 83% male, 37% unstable angina and 10% acute MI. The left
anterior descending bifurcation was involved in 53% of cases and distal left main in 8%.
Type B treatment (provisional T stenting of the side branch) was used in 74% of cases,
Type A (Systematic T stenting, the side branch first) in 18%, Type D (V stenting) in 6%
and Type C (Culotte) in 2%. The main branch (proximal reference diameter 3.1+0.5 mm)
was stented in 98.6 % of cases and the side branch (2.4+1.1 mm) in 37.2%. Angio-
graphic success (residual stenosis < 30%) was obtained in 96.3% of cases for the main
branch and 92.9 % for the side branch. The ischemic driven TVR rate at 7 months follow-
up was 13.2%. Predictors of TVR by univariate analysis were acute coronary syndrome
(12.3 vs 8.6%; OR 4.6, p = 0.001), period 1996-98 vs 1999-2002 (16.2 vs 11.8%; OR
0.67, p = 0.01), reference main branch diameter < 2.7 mm (18.8 vs 12.7%; OR 1.53, p =
0.065), non use of type B treatment (24.2 vs 11.0%; OR 0.48, p = 0.001), use of 2 stents
(19.1 vs 10.0%; OR 1.92, p = 0.001) and type 4 lesions compared to type 3 lesions (8.3
vs 22.1%; OR 4.6, p = 0.001). By multivariate analysis, independant predictors of 7-
months TVR were acute coronary syndromes (OR 6.74, p = 0.001, 95 % CI : 4.66 –
9.88), reference diameter < 2.7 mm (odds ratio 2.03, p = 0.006, 95 % CI : 1.22 – 2.38)
and non-use of type B treatment (odds ratio 0.46, p = 0.001, 95 % CI :0.31 – 0.67).
Conclusion: Stenting of bifurcation lesions is associated with a high rate of angiographic
success and an acceptable rate of ischemic driven TVR at 7 months. Independent pre-
dictors of TVR are acute coronary syndrome, small reference diameter and strategies
other than provisional T stenting
1081-51 AST SLK-View™: A Novel Approach for Treatment of 
Bifurcation Lesions
Jeffrey W. Moses, Patrick Whitlow, Maurice Buchbinder, Jeffrey J. Popma, The 
Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, 
New York
Background. Treatment of bifurcation lesions is one of the main challenges of interven-
tional cardiology. Wile maintaining sufficient vessel support and side branch access,
SLK-View™ Stent offers a promising approach for the treatment of coronary bifurcation
lesions. The aim of this prospective, multicenter trial was to evaluate the safety and feasi-
bility of the SLK-View™ Stent for treatment of a de novo lesion that involves a major par-
ent coronary artery and side branch. Methods and Results. A total of 31 pts (67.7 % -
male; mean age 61.3±10 years) were treated. Follow-up included clinical assessment at
30 days and angiographic study at 6 months. The location of bifurcations was most fre-
quent in left descending artery/diagonal branch (84%), and was followed by right coro-
nary artery/posterior descending artery (10%) and circumflex/obtuse marginal branch
(6%). Stent was successfully delivered to bifurcations in all but 2 pts (93.5%). Procedural
success defined as <50% residual stenosis of the parent vessel in the absence of major
adverse cardiac events (MACE) was achieved in all pts with successful stent deployment.
Six-month MACE were observed in 14(45.1%) pts and were represented by target lesion
revascularization in the majority of pts (41.9%). Other results are presented in the Table.
Conclusions. SLK-View™ Stent is a safe and effective new solution for treatment of bifur-
cation lesions. Anti-restenosis drug elution should be considered in this high risk popula-
tion with this successful platform.
1081-52 Prediction of Death or Myocardial Infarction by Exercise 
SPECT Scintigraphy Among Patients Who Have Had 
Recent Coronary Stenting
Vivek Rajagopal, Hitinder S. Gurm, Richard C. Brunken, Claire E. Pothier, Deepak L. 
Bhatt, Michael S. Lauer, Cleveland Clinic Foundation, Cleveland, OH
Background: Although practice guidelines do not recommend routine exercise- testing
of patients after coronary stenting, several small studies have suggested that stress myo-
cardial perfusion imaging can provide prognostic information about future adverse car-
diac events.
Methods: We analyzed 420 patients who underwent dual isotope exercise nuclear scin-
tigraphy after coronary stenting between April 1996 and May 2002.Mild ischemia was
defined as reversible perfusion defects involving 6-18% of myocardial mass, while severe
ischemia involved more than 18% of myocardial mass. The primary endpoint was all-
cause mortality or myocardial infarction during a median of 12 months (range 1 to 60) of
follow-up.
Results: There were 101 patients (24%) who had mild or severe ischemia. Major events
(death or MI) occurred in 70 patients including 24 deaths. Among patients with no
ischemia the 1-year event rate was 6.2%, whereas among patients with mild or severe
ischemia, the event rates were 11.4% and 9.8% (P=0.006). After adjusting for age, gen-
der, standard cardiac risk factors, cardiac history, left ventricular ejection fraction, angio-
graphic findings, procedural variables, exercise capacity and heart rate dynamics, the
presence of scintigraphic evidence of ischemia predicted death or MI (adjusted hazard
ratio for 1 SD increase in mass of ischemic myocardium 1.37, 95% CI=1.11-1.68,
p=0.003). The presence of ischemia similarly predicted events in asymptomatic patients.
Conclusions: Among patients who have undergone recent coronary stent placement,
nuclear perfusion defects independently predicted risk of death or myocardial infarction.
1081-53 Debulking of Chronic Total Occlusions With Rotational 
or Directional Atherectomy Before Stenting Trial: A 
Multicenter Randomized Study
Etsuo Tsuchikane, Takahiko Suzuki, Yasushi Asakura, Osamu Katoh, Hirotaka Oda, 
Kinzo Ueda, Takahiro Tanaka, Tetsuo Matsubara, Kenshi Fujii, Yung-Sheng Hsu, Hideo 
Tamai, The DOCTORS Investigators, Osaka Medical Center for Cancer and 
Cardiovascular Diseases, Osaka, Japan, Toyohashi Heart Center, Toyohashi, Japan
Background: Previous randomized studies have shown that stenting reduces restenosis
and reocclusion rates of successfully recanalized chronic coronary total occlusions
(CTO) compared with balloon angioplasty (BA) alone, however the restenosis rate after
stenting still remains high. Calcified plaque or massive plaque burden in CTO is consid-
ered to interfere with full stent expansion and be a cause of restenosis. Methods: DOC-
TORS (Debulking Of CTO with Rotational or directional atherectomy before Stenting) is a
multicenter randomized trial aimed to examine the efficacy of pre-stent plaque debulking
by rotational or directional atherectomy (RA/DCA) on reduction of restenosis. After suc-
cessful recanalization of CTO (TIMI flow =< 1, estimated occlusive duration >= 1 month)
by using a conventional wire, the physician determined the indication of RA or DCA.
Then, patients were randomly assigned to the debulking (D) group or the non-debulking
(ND) group according to the debulking device the physician decided. In the D group, RA
or DCA was performed and stents were implanted to fully cover the lesion. In the ND
group, stents were implanted after conventional BA. Serial quantitative angiography
(QCA) and intravascular ultrasound (IVUS) examination were performed at the procedure
and 6 month follow-up (Fu). The primary endpoint was the angiographic restenosis rate.
Secondary endpoints were clinical outcomes by 1 year and QCA and IVUS parameters.
Results: In Japanese 21 centers, 271 patients were enrolled (~ July 2003). Of those, 138
patients were assigned to the D (RA: 90, DCA: 48) and 133 to the ND group. Baseline
characteristics did not differ. There were 4 unsuccessful cases; 3 in the D and 1 in the ND
group (NS). Major adverse cardiac event rate by 30 days was also similar (1.6% versus
0%). Total implanted stent length was significantly longer in the ND group (25.7±10.8 ver-
sus 28.8±12.0 mm; p=0.03). Fu angiographic data has been collected in 197 patients to
date. Target vessel revascularization rate was higher in the ND group (26.8 versus
41.2%; p=0.04). Conclusion: Pre-stent debulking for CTO is safe and may be effective in
prevention of restenosis. Final Fu angiographic results and QCA data will be presented.
1081-54 Effect of Diabetes on Five-Year Outcomes After 
Coronary Stent Implantation
Donald E. Cutlip, Manish S. Chauhan, David R. Holmes, Julian M. Aroesty, Amit 
Chhabra, Ralph A. D'Agostino, Joseph P. Carrozza, Jr., Kalon K.L. Ho, Harvard Clinical 
Research Institute, Boston, MA, Beth Israel Deaconess Medical Center, Boston, MA
Background: Diabetes (DM) is associated with significantly increased clinical restenosis
in the first year after coronary stenting. The DM effect on target lesion stability after one
year and long-term overall cardiac clinical outcome after second-generation coronary
stents has not been reported. Methods: We reviewed clinical outcomes for a subset of
patients consented for long-term follow-up as part of pivotal stent trials evaluated for FDA
approval. We report pooled data for 1228 such patients with mean 4.4 years follow-up. A
Cox proportional hazards model was used to evaluate the independent effect of diabetes
on overall mortality and the 5-year composite cardiac event rate. Results: DM patients
were older (64 ± 10 vs. 62 ± 11 years, p=0.008), more frequently women (41% vs. 29%,
p=0.001) and had more frequent 3 vessel disease (11.4% vs. 7.1%, p=0.02). At one year,
target lesion revascularization (TLR) was significantly more common for DM (Table). Dur-
ing years 2-5, TLR was infrequent in either group, but the incidence of ischemic events
and death was increased among DM patients. DM was a significant independent predic-
tor of the 5-year composite outcome (Hazard Ratio 1.5, p=0.0001). Conclusions: 1) Dia-
betes was not associated with increased TLR after one year. 2) Despite similar stability of
Quantitative Angiographic Data at Baseline and 6-Month Follow-up
Characteristic Parent vessel Branch vessel
Pre-PCI Post-PCI At 6 
months
Pre-PCI Post-PCI At 6 
months
Reference vessel 
diameter, mm
2.9±0.4 - - 2.2±0.4 - -
Minimal lumen 
diameter, mm
1.1±0.4 2.3±0.5 1.51±0.76 1.4±0.4 1.7±0.4 1.2±0.6
Percent stenosis, 
%
63.1±12.8 23.5±8.0 49.0±22 37.7±16.7 24.2±13.5 41±26
Vessel with 
percent 
stenosis<50%, n 
(%)
- 29 
(100%)
12 (48%) - - 8 (32%)
